Franchi F, Luisi M
J Int Med Res. 1977;5(1):53-60. doi: 10.1177/030006057700500109.
Six women with normal menstrual cycles were treated over six cycles with Fysioquens, a normophasic contraceptive consisting of 7 tablets of ethinyloestradiol (EE) 0-050 mg and 15 tablets containing 1-0 mg lynestrenol + 0-050 mg EE. In the 1st, 3rd and 6th treatment cycles and in the cycles before and after treatment, hormonal assays and other tests were carried out to determine whether ovulation had occurred. No treatment cycles showed any signs of ovulation, but it did occur in the pre-and post-treatment cycles. Blood pressures and liver function tests remained normal, but two of the six volunteers showed a slight increase in body-weight.
六名月经周期正常的女性接受了六个周期的Fysioquens治疗，Fysioquens是一种正常相避孕药，由7片含0.050毫克乙炔雌二醇（EE）的片剂和15片含1.0毫克炔诺酮醇 + 0.050毫克EE的片剂组成。在第1、3和6个治疗周期以及治疗前后的周期中，进行了激素检测和其他测试，以确定是否发生排卵。没有治疗周期显示出任何排卵迹象，但在治疗前和治疗后的周期中确实发生了排卵。血压和肝功能测试保持正常，但六名志愿者中有两名体重略有增加。
